DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) ("Intermap” or the "Company”), a global leader in 3D geospatial products and intelligence solutions, today ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $21.5, a high estimate of $26.00 ...

Analysts have recently evaluated Alcoa and provided 12-month price targets. The average target is $45.75, accompanied by a ...

Over a 15-year span, Sweetgreen expanded fivefold to 150 locations as it approached the doorstep of going public in late 2021. But that run wasn’t the premise behind the $6 billion valuation it ...

Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable ...

Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. See why I think ILMN stock is an appealing ...

Today, the Congressional Budget Office (CBO) released its March 2025 Long-Term Budget Outlook, which builds off its ...

Not all corners of the market are moving in the same direction this year; 2025 has already delivered a few surprises for ...

We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...

BI-covered insurance brokers may have room for upside to average consensus organic sales growth of 5-6% in 2025 even as price ...

Tempus AI leverages AI for treatment decisions and diagnostics, thriving in the booming healthcare AI market with strong ...

Researchers in Canada have compared strawberry growth under uniform illumination from semi-transparent thin-film cadmium ...